ArticleHeliyon2024

Pan-cancer identified ARPC1B as a promising target for tumor immunotherapy and prognostic biomarker, particularly in READ.

Chenxiong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.